finanzen.net
12.09.2019 01:15
Bewerten
(0)

P genotyping market was valued at USD 12.3 billion in 2018, and is estimated to be valued at USD 38.6 billion in 2024, witnessing a CAGR of 21%

NEW YORK, Sept. 11, 2019 /PRNewswire/ --

Market Overview
The global SNP genotyping market was valued at USD 12.3 billion in 2018, and is estimated to be valued at USD 38.6 billion in 2024, witnessing a CAGR of 21%. The analysis of SNPs is widely utilized in different disciplines of genetics and related studies, commonly associated with studying genetic determinants of many complex diseases. SNP technologies are extensively utilized for detection and are beneficial in the etiology of several human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, among others.



Read the full report: https://www.reportlinker.com/p05815073/?utm_source=PRN



In addition, SNPs are essential markers in various human ailments and are intensely employed in pharmacogenomics to customize personalized medicine in a better way. Therefore, rising applications of SNPs in several life sciences and biotechnology aspects are driving the SNP genotyping market.

Scope of the Report
Single-nucleotide polymorphism (SNP) refers to mutations found at a specific locus or single base pair mutation containing two alleles. SNPs aid in understanding the correlations between the genotype and behavior indicated by all living organisms. It involves the measurement of variations that commonly occur in individuals. Unlike conventional time-consuming, expensive, and labor-extensive detection technologies, SNP technology is highly efficient, relatively inexpensive, and automated.

Key Market Trends
Pharmogenics Led the End-user Segment of the SNP Genotyping Market in 2018

Under end users, pharmacogenomics is the leading segment. The large share of pharmacogenomics is primarily due to the increasing pipeline for personalized medicine and novel drug delivery systems, which are extensively exploiting SNP in genetic materials for drug development applications.

North America had Largest Share in 2018 in the Global SNP Market, while Asia-Pacific is the Fastest-growing Region

North America is the dominating region in the SNP genotyping market, due to rising commercial research in personalized medicines and animal breeding, among others.

In addition, Asia-Pacific is the fastest-growing market, due to the rising demand for SNP genotyping in emerging economies like China and India, across different fields, which is largely propelling the market's growth.

Competitive Landscape
The SNP genotyping market is highly competitive and consists of several major players. In terms of market share, a small number of major players currently dominate the market. Key strategies adopted by major players in this market include product launches, collaborations, and agreements.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support

Read the full report: https://www.reportlinker.com/p05815073/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/p-genotyping-market-was-valued-at-usd-12-3-billion-in-2018--and-is-estimated-to-be-valued-at-usd-38-6-billion-in-2024--witnessing-a-cagr-of-21-300916134.html

SOURCE Reportlinker

Werbung
Werbung
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX unter Druck -- Dow leichter -- Thomas Cook stellt Insolvenzantrag -- Deutsche Wirtschaft fällt im September in Rezessionsbereich -- BVB, Adler Real Estate, DEUTZ, Wirecard im Fokus

Allianz und Co.: Große Investoren wollen Billionen klimafreundlich anlegen. BASF verkauft Geschäft mit Ultrafiltrationsmembranen an DuPont. Vonovia übernimmt Mehrheit an schwedischer Hembla. Geplanter Verkauf des Aktienhandels: Deutsche Bank schließt Vereinbarung mit BNP.

Die 5 beliebtesten Top-Rankings

Apple nicht mehr Platz 1
Das sind die wertvollsten Unternehmen der Welt 2019
Die wertvollsten Fußballvereine der Welt 2019
Welcher Club ist am wertvollsten?
Die 12 toten Topverdiener 2019
Diese Legenden sind die bestbezahlten Toten der Welt
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
mehr Top Rankings

Umfrage

Die Bundesregierung hat ein Milliarden-Paket für den Klimaschutz beschlossen. Glauben Sie an dessen Wirksamkeit?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Thomas CookA0MR3W
Deutsche Bank AG514000
TUITUAG00
Daimler AG710000
CommerzbankCBK100
NEL ASAA0B733
Microsoft Corp.870747
Amazon906866
Apple Inc.865985
Infineon AG623100
BASFBASF11
BayerBAY001
Ballard Power Inc.A0RENB
K+S AGKSAG88